Literature DB >> 26309630

The positive therapeutic effect in a patient of Evans syndrome combined with acute myocardial infarction.

Yuwei Zhang1, Kai Zheng2, Miao Zheng3, Qigong Liu4, Li Meng3.   

Abstract

Evans syndrome (ES) is a rare combination of autoimmune hemolytic anemia and thrombocytopenia. This case report details an old male ES patient with acute myocardial infarction. He was successfully treated by primary percutaneous coronary intervention in the case of low hemoglobin level (60 g/L). Considering ES recurrence after surgery, he was given human immunoglobulin, methyl prednisolone and TPO treatment. On the basis of his platelet count, the patient was required to take only one anti-platelet drug or stop all anti-platelet drugs. To the best of our knowledge, this is the first report of ES with AMI. This case suggests that primary PCI can be a useful therapeutic strategy even if patient has low hemoglobin level, but careful balance between anti-platelet therapy and efforts to raise platelet count are needed after surgery.

Entities:  

Keywords:  Evans syndrome (ES); PCI; acute myocardial infarction (AMI); anti-platelet therapy

Year:  2015        PMID: 26309630      PMCID: PMC4538027     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura.

Authors:  T Fuchi; T Kondo; K Sase; M Takahashi
Journal:  Jpn Circ J       Date:  1999-02

Review 2.  Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Authors:  Shaun Bhatty; Asghar Ali; Ranjith Shetty; Kevin F Sumption; Michael J Cowley; Ion S Jovin
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04

Review 3.  Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations.

Authors:  William S Weintraub; Leonid Mandel; Sandra A Weiss
Journal:  Pharmacoeconomics       Date:  2013-11       Impact factor: 4.981

Review 4.  How I treat idiopathic thrombocytopenic purpura (ITP).

Authors:  Douglas B Cines; James B Bussel
Journal:  Blood       Date:  2005-06-07       Impact factor: 22.113

Review 5.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Faulty blood typing misled by auto anti-D in AIHA.

Authors:  Guining Li; Fenghua Chen; Shenzong Rao; Lihua Hu
Journal:  Transfus Apher Sci       Date:  2014-01-24       Impact factor: 1.764

Review 7.  Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.

Authors:  Aleksandar N Neskovic; Ivan Stankovic; Predrag Milicevic; Aleksandar Aleksic; Alja Vlahovic-Stipac; Branko Calija; Biljana Putnikovic
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

8.  [A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura].

Authors:  Sayaka Kikuchi; Yutaka Hayashi; Seiji Fujioka; Hitoshi Kukita; Naoto Ochi
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2002-01

9.  Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura.

Authors:  Maria Cruz Ferrer Gracia; Isabel Calvo Cebollero; Juan Sánchez-Rubio Lezcano; Gabriel Galache Osuna; José Antonio Diarte Miguel; Luis Placer Peralta
Journal:  Int J Cardiol       Date:  2007-07-31       Impact factor: 4.164

10.  [Study on blood ABO typing in patients with autoimmune hemolytic anemia].

Authors:  Jian-Ying Zhu; Jiong-Cai Lan; Li-Ya Hu; Qing-Bao Meng; Hong-Qing Luo
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.